ABVC BioPharma's total assets for Q1 2026 were $19.73M, a decrease of -6.31% from the previous quarter. ABVC total liabilities were $6.90M for the fiscal quarter, a -11.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.